296 related articles for article (PubMed ID: 20336052)
1. The renin-angiotensin-aldosterone system in peritoneal dialysis: is what is good for the kidney also good for the peritoneum?
Nessim SJ; Perl J; Bargman JM
Kidney Int; 2010 Jul; 78(1):23-8. PubMed ID: 20336052
[TBL] [Abstract][Full Text] [Related]
2. An update on RAAS blockade and peritoneal membrane preservation: the ace of art.
Wontanatawatot W; Eiam-Ong S; Leelahavanichkul A; Kanjanabuch T
J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S175-83. PubMed ID: 22043587
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
[TBL] [Abstract][Full Text] [Related]
4. Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients.
Aguilera A; Yáñez-Mo M; Selgas R; Sánchez-Madrid F; López-Cabrera M
Curr Opin Investig Drugs; 2005 Mar; 6(3):262-8. PubMed ID: 15816502
[TBL] [Abstract][Full Text] [Related]
5. Inflammation, neoangiogenesis and fibrosis in peritoneal dialysis.
de Lima SM; Otoni A; Sabino Ade P; Dusse LM; Gomes KB; Pinto SW; Marinho MA; Rios DR
Clin Chim Acta; 2013 Jun; 421():46-50. PubMed ID: 23466603
[TBL] [Abstract][Full Text] [Related]
6. Mediators of inflammation and fibrosis.
Lai KN; Tang SC; Leung JC
Perit Dial Int; 2007 Jun; 27 Suppl 2():S65-71. PubMed ID: 17556333
[TBL] [Abstract][Full Text] [Related]
7. Influence of renin-angiotensin-aldosterone system-blocking drugs on peritoneal membrane in peritoneal dialysis patients.
Trošt Rupnik A; Pajek J; Guček A; Osredkar J; Kovač D; Bren A; Klančič D; Saksida S; Rus I; Globokar M; Drozg A; Lešnik M; Plešivčnik Z; Ekart R; Lopert S; Lindič J
Ther Apher Dial; 2013 Aug; 17(4):425-30. PubMed ID: 23931884
[TBL] [Abstract][Full Text] [Related]
8. [Selected indices of peritoneal fibrosis in patients undergoing peritoneal dialysis].
Penar J; Weyde W; Krajewska M; Madziarska K; Gołebiowski T; Szymczak M; Kłak R; Klinger M
Postepy Hig Med Dosw (Online); 2009 Apr; 63():200-4. PubMed ID: 19502680
[TBL] [Abstract][Full Text] [Related]
9. PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage.
Sandoval P; Loureiro J; González-Mateo G; Pérez-Lozano ML; Maldonado-Rodríguez A; Sánchez-Tomero JA; Mendoza L; Santamaría B; Ortiz A; Ruíz-Ortega M; Selgas R; Martín P; Sánchez-Madrid F; Aguilera A; López-Cabrera M
Lab Invest; 2010 Oct; 90(10):1517-32. PubMed ID: 20531289
[TBL] [Abstract][Full Text] [Related]
10. Update on mechanisms of ultrafiltration failure.
Kim YL
Perit Dial Int; 2009 Feb; 29 Suppl 2():S123-7. PubMed ID: 19270200
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure.
López-Cabrera M; Aguilera A; Aroeira LS; Ramírez-Huesca M; Pérez-Lozano ML; Jiménez-Heffernan JA; Bajo MA; del Peso G; Sánchez-Tomero JA; Selgas R
Perit Dial Int; 2006; 26(1):26-34. PubMed ID: 16538870
[TBL] [Abstract][Full Text] [Related]
12. High glucose dialysate-induced peritoneal fibrosis: Pathophysiology, underlying mechanisms and potential therapeutic strategies.
Zhao H; Zhang HL; Jia L
Biomed Pharmacother; 2023 Sep; 165():115246. PubMed ID: 37523983
[TBL] [Abstract][Full Text] [Related]
13. Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis.
Liappas G; González-Mateo G; Aguirre AR; Abensur H; Albar-Vizcaino P; Parra EG; Sandoval P; Ramírez LG; Del Peso G; Acedo JM; Bajo MA; Selgas R; Sánchez Tomero JA; López-Cabrera M; Aguilera A
Oncotarget; 2016 May; 7(21):30133-46. PubMed ID: 27102153
[TBL] [Abstract][Full Text] [Related]
14. Calcitriol decreases TGF-β1 and angiotensin II production and protects against chlorhexide digluconate-induced liver peritoneal fibrosis in rats.
Lee CJ; Subeq YM; Lee RP; Liou HH; Hsu BG
Cytokine; 2014 Jan; 65(1):105-18. PubMed ID: 24210651
[TBL] [Abstract][Full Text] [Related]
15. Sterile solutions and peritoneal inflammation.
Flessner MF
Contrib Nephrol; 2006; 150():156-165. PubMed ID: 16721006
[TBL] [Abstract][Full Text] [Related]
16. Preventing peritoneal membrane fibrosis in peritoneal dialysis patients.
Zhou Q; Bajo MA; Del Peso G; Yu X; Selgas R
Kidney Int; 2016 Sep; 90(3):515-24. PubMed ID: 27282936
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase C α inhibition prevents peritoneal damage in a mouse model of chronic peritoneal exposure to high-glucose dialysate.
Wang L; Balzer MS; Rong S; Menne J; von Vietinghoff S; Dong L; Gueler F; Jang MS; Xu G; Timrott K; Tkachuk S; Hiss M; Haller H; Shushakova N
Kidney Int; 2016 Jun; 89(6):1253-67. PubMed ID: 27142955
[TBL] [Abstract][Full Text] [Related]
18. Octreotide lessens peritoneal injury in experimental encapsulated peritoneal sclerosis model.
Ertilav M; Hur E; Bozkurt D; Sipahi S; Timur O; Sarsik B; Akcicek F; Duman S
Nephrology (Carlton); 2011 Aug; 16(6):552-7. PubMed ID: 21382127
[TBL] [Abstract][Full Text] [Related]
19. Neoangiogenesis in the peritoneal membrane.
Krediet RT; Zweers MM; van der Wal AC; Struijk DG
Perit Dial Int; 2000; 20 Suppl 2():S19-25. PubMed ID: 10911638
[TBL] [Abstract][Full Text] [Related]
20. Acidic organelles mediate TGF-β1-induced cellular fibrosis via (pro)renin receptor and vacuolar ATPase trafficking in human peritoneal mesothelial cells.
Oba-Yabana I; Mori T; Takahashi C; Hirose T; Ohsaki Y; Kinugasa S; Muroya Y; Sato E; Nguyen G; Piedagnel R; Ronco PM; Totsune K; Ito S
Sci Rep; 2018 Feb; 8(1):2648. PubMed ID: 29422602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
